Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 20/Signature 2
From BugSigDB
Needs review
Source: Additional file 11: Figure S11
Description: Differentially abundant between the Naive group and HR (H-Isoniazid, R-Rifampin) treatment group.
Abundance in Group 1: decreased abundance in HR (H-Isoniazid, R-Rifampin)
Revision editor(s): KateRasheed